Scarica l'app Stockscreener
185.35
2.81%
5.06
Pre-mercato:
185.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ORCL Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$180.29
Aprire:
$182.125
Volume 24 ore:
23.15M
Relative Volume:
0.79
Capitalizzazione di mercato:
$533.08B
Reddito:
$64.08B
Utile/perdita netta:
$16.40B
Rapporto P/E:
33.28
EPS:
5.5698
Flusso di cassa netto:
$-24.74B
1 W Prestazione:
+11.68%
1M Prestazione:
+26.62%
6M Prestazione:
-25.95%
1 anno Prestazione:
+24.15%
Intervallo 1D:
$179.00
$186.52
Intervallo di 1 settimana:
$160.33
$186.52
Portata 52W:
$134.57
$345.72
Oracle Corp Stock (ORCL) Company Profile
Nome
Oracle Corp
Settore
Industria
Telefono
(737) 867-1000
Indirizzo
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL vs MSFT, PLTR, CRWD, SNPS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
185.35 | 518.52B | 64.08B | 16.40B | -24.74B | 5.5698 |
MSFT
Microsoft Corp
|
411.38 | 3.07T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
135.91 | 350.06B | 5.22B | 2.29B | 2.69B | 0.889 |
CRWD
Crowdstrike Holdings Inc
|
476.53 | 119.01B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
502.51 | 95.30B | 8.00B | 1.10B | 2.28B | 6.4708 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | Wedbush | Outperform |
| 2026-04-10 | Downgrade | Cleveland Research | Buy → Neutral |
| 2026-03-24 | Ripresa | BofA Securities | Buy |
| 2026-03-11 | Reiterato | BMO Capital Markets | Outperform |
| 2026-03-11 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2026-03-11 | Reiterato | Oppenheimer | Outperform |
| 2026-02-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2026-02-09 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2026-02-09 | Downgrade | Melius | Buy → Hold |
| 2026-02-04 | Reiterato | BMO Capital Markets | Outperform |
| 2026-01-12 | Ripresa | Goldman | Buy |
| 2025-12-11 | Reiterato | BMO Capital Markets | Outperform |
| 2025-12-03 | Iniziato | Wells Fargo | Overweight |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-13 | Reiterato | BMO Capital Markets | Outperform |
| 2025-10-09 | Iniziato | Robert W. Baird | Outperform |
| 2025-09-25 | Iniziato | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Reiterato | BMO Capital Markets | Outperform |
| 2025-09-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-09-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-09-09 | Reiterato | BMO Capital Markets | Outperform |
| 2025-07-17 | Iniziato | Scotiabank | Sector Outperform |
| 2025-07-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Reiterato | BMO Capital Markets | Outperform |
| 2025-06-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-18 | Reiterato | Guggenheim | Buy |
| 2025-06-13 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-04-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Iniziato | Stephens | Equal-Weight |
| 2025-03-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-03-03 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Aggiornamento | Melius | Hold → Buy |
| 2024-09-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-09-10 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-04-18 | Iniziato | Oppenheimer | Perform |
| 2024-03-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Aggiornamento | Argus | Hold → Buy |
| 2024-03-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-03-12 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-11-13 | Aggiornamento | Edward Jones | Hold → Buy |
| 2023-10-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Iniziato | HSBC Securities | Buy |
| 2023-09-14 | Aggiornamento | DZ Bank | Hold → Buy |
| 2023-09-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Aggiornamento | UBS | Neutral → Buy |
| 2023-06-13 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Downgrade | Societe Generale | Buy → Hold |
| 2023-01-18 | Iniziato | DA Davidson | Neutral |
| 2023-01-11 | Iniziato | Mizuho | Buy |
| 2023-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-10-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Iniziato | Berenberg | Hold |
| 2022-08-12 | Iniziato | Guggenheim | Buy |
| 2022-06-29 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Ripresa | Goldman | Sell |
| 2022-06-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Iniziato | Daiwa Securities | Neutral |
| 2022-03-29 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-12-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Aggiornamento | DZ Bank | Sell → Hold |
| 2021-12-10 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-12-10 | Reiterato | Barclays | Equal Weight |
| 2021-12-10 | Reiterato | Citigroup | Neutral |
| 2021-12-10 | Reiterato | Cowen | Outperform |
| 2021-12-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Reiterato | Piper Sandler | Neutral |
| 2021-12-10 | Reiterato | Societe Generale | Hold |
| 2021-12-10 | Reiterato | Stifel | Hold |
| 2021-12-10 | Reiterato | UBS | Neutral |
| 2021-12-10 | Reiterato | Wolfe Research | Peer Perform |
| 2021-11-16 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Deutsche Bank | Hold |
| 2021-09-14 | Reiterato | BMO Capital Markets | Market Perform |
| 2021-09-14 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Downgrade | DZ Bank | Hold → Sell |
| 2021-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Iniziato | Wolfe Research | Peer Perform |
| 2021-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2021-04-01 | Ripresa | Wedbush | Neutral |
| 2021-03-22 | Ripresa | Evercore ISI | In-line |
| 2021-03-16 | Ripresa | Credit Suisse | Outperform |
| 2021-03-11 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Downgrade | Societe Generale | Buy → Hold |
| 2021-03-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Ripresa | Citigroup | Neutral |
| 2021-01-22 | Iniziato | Goldman | Sell |
| 2020-12-18 | Aggiornamento | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Ripresa | BofA Securities | Neutral |
| 2020-12-08 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Ripresa | UBS | Neutral |
| 2020-09-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Reiterato | BMO Capital Markets | Market Perform |
| 2020-09-11 | Reiterato | Barclays | Equal Weight |
| 2020-09-11 | Reiterato | Credit Suisse | Outperform |
| 2020-09-11 | Reiterato | Goldman | Buy |
| 2020-09-11 | Reiterato | Jefferies | Hold |
| 2020-09-11 | Reiterato | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-09-11 | Reiterato | Stifel | Hold |
| 2020-09-11 | Reiterato | Wells Fargo | Overweight |
| 2020-06-19 | Downgrade | Argus | Buy → Hold |
| 2020-06-01 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Reiterato | BMO Capital Markets | Market Perform |
Mostra tutto
Oracle Corp Borsa (ORCL) Ultime notizie
Alpha Cubed Investments LLC Increases Stake in Oracle Corporation $ORCL - MarketBeat
Oracle screams Buy after 50% Crash since September High - FXLeaders
Oracle Gains Strength In NYSE Composite Cloud AI Momentum - Kalkine Media
Oracle (NYSE:ORCL) Shares Up 2.8%Still a Buy? - MarketBeat
Oracle stock rises after Michigan data center wins $16B financing commitment - Traders Union
Wedbush Brushes Off AI Concerns, Sticks With Oracle Corporation (ORCL) - Insider Monkey
Oracle Stock Is Still Down Year to Date, As Many AI Stocks Soar. Here's What's Going On. - The Globe and Mail
Raising the bar for trustworthy AI at Oracle: ISO/IEC 42001 certification for OCI, Oracle Health, Oracle SaaS, and NetSuite - Oracle Blogs
Oracle Stock Is Still Down Year to Date, As Many AI Stocks Soar. Here's What's Going On. - The Motley Fool
Oracle Corporation (ORCL) Slides on AI Spending Concerns – Is This a Buying Opportunity? - Yahoo Finance
Oracle will patch more often to counter AI cybersecurity threat - cio.com
Intel Is Now Worth More Than Oracle as Its Stock Explodes Higher - 富途牛牛
Intel is now worth more than Oracle as its stock explodes higher - MarketWatch
Oracle Stock Forecast: What’s Driving Momentum Now - Kalkine Media
Why Is Oracle Stock Surging On Tuesday? - Benzinga
Oracle Supports Africa Clinical Research Network to Advance a New Era of Clinical Research, Launches First Trial - Investing News Network
Oracle AI to be integrated into DoD classified networks - SDxCentral
Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial - Oracle
Oracle supports Africa clinical trial network’s first study - Investing.com
Oracle partners with Africa Clinical Research Network for first trial - StreetInsider
Highland Capital Management LLC Lowers Stake in Oracle Corporation $ORCL - MarketBeat
QRG Capital Management Inc. Has $46.51 Million Stake in Oracle Corporation $ORCL - MarketBeat
Micron Tech and Oracle among market cap stock movers on Monday - Investing.com
3,876 Shares in Oracle Corporation $ORCL Purchased by Fulcrum Wealth Advisors LLC - MarketBeat
Alliance Wealth Advisors LLC UT Has $4.79 Million Stock Position in Oracle Corporation $ORCL - MarketBeat
IHH Healthcare Unifies Enterprise Systems with Oracle Fusion Cloud Applications to Strengthen Care Delivery Across Markets - PR Newswire
Oracle Stock Up 5.2% on May 5, 2026 Following Strong Peers' EarningsNews and Statistics - IndexBox
Why is Oracle stock climbing today? By Investing.com - Investing.com Nigeria
Oracle (NYSE:ORCL) Shares Up 5%Here's What Happened - MarketBeat
IBM and Oracle Expand Partnership to Help Organizations Modernize with AI and Cloud - IBM Newsroom
I’m Calling A Bottom For Oracle (NYSE:ORCL) - Seeking Alpha
Oracle Corp. stock outperforms competitors on strong trading day - MarketWatch
What Oracle Investors Need to Know About OpenAI's Struggles - The Motley Fool
Oracle (ORCL) Secures Financing for Data Center in Michigan - Yahoo Finance
Salesforce vs Oracle: There’s Only One Winner In the Cloud AI Push - AOL.com
Why Oracle Stock Popped Today - TradingView
The AI Job Shake-Up Could Create Big Winners – and Losers - InvestorPlace
Micron, Oracle among market cap stock movers on Monday - Investing.com
Bloom Energy Stock (BE) Opinions on Q1 Earnings and Oracle Partnership - Quiver Quantitative
Oracle Project Jupiter Puts AI Power Costs And Valuation In Focus - Yahoo Finance
Oracle Secures Classified AI Deal With US Defense Department - Benzinga
Micron Tech and Oracle among market cap stock movers on Monday By Investing.com - Investing.com South Africa
Why is Oracle stock climbing today? - Investing.com
21 New 4-Star Stocks This Week - Morningstar
Ignore the OpenAI Panic and Keep Buying Oracle Stock, Says Wedbush - Barchart.com
Oracle’s Pentagon AI Deal Puts Its Cloud Bet Back in the Spotlight - TechStock²
Oracle Stock Rallies As Traders Reassess AI Cloud Upside - timothysykes.com
Fund Update: 37,323 ORACLE (ORCL) shares added to Applied Finance Capital Management, LLC portfolio - Quiver Quantitative
Varma Mutual Pension Insurance Co Reduces Position in Oracle Corporation $ORCL - MarketBeat
Oracle Wins Pentagon Clearance for Classified AI Networks as Shares Stage Recovery - AD HOC NEWS
Peregrine Asset Advisers Inc. Sells 16,574 Shares of Oracle Corporation $ORCL - MarketBeat
Oracle Corp Azioni (ORCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.93%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):